Evaluation of Some Novel 1, 5- Diphenyl-2, 4-Disubstituted- 1H-Imidazole for the Antioxidant Activity.

Main Article Content

Sonawane Rutuja
K. Karthickeyan


Numerous diseases, including diabetes, atherosclerosis, cancer, and neurological and cardiovascular diseases, are caused by oxidative stress. Therapeutic antioxidants are promising options for preventing and treating illnesses caused by oxidative stress. We present the design, Antioxidant Activity of Some 1, 5- Diphenyl-2, 4-Disubstituted- 1H-Imidazole by two methods Ferric reducing antioxidant power (FRAP) and DPPH method.

Article Details

How to Cite
Sonawane Rutuja, & K. Karthickeyan. (2023). Evaluation of Some Novel 1, 5- Diphenyl-2, 4-Disubstituted- 1H-Imidazole for the Antioxidant Activity. Journal of Coastal Life Medicine, 11(1), 2564–2569. Retrieved from https://www.jclmm.com/index.php/journal/article/view/718


Shingalapur, R.V.; Hosamani, K.M.; Keri, R.S. Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles. Eur. J. Med. Chem. 2009, 44, 4244–4248. [CrossRef] [PubMed]

Achar, K.C.; Hosamani, K.M.; Seetharamareddy, H.R. In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives. Eur. J. Med. Chem. 2010, 45, 2048–2054. [CrossRef] [PubMed] Appl. Sci. 2020, 10, 2889 18 of 20

De Luca, L. Naturally occurring and synthetic imidazoles: Their chemistry and their biological activities. Curr. Med. Chem. 2006, 13, 1–23. [CrossRef] [PubMed]

Heravi, M.M.; Daraie, M.; Zadsirjan, V. Current advances in the synthesis and biological potencies of tri- and tetra-substituted 1H-imidazoles. Mol. Divers. 2015, 19, 577–623. [CrossRef] [PubMed]

Ghorbani-Vaghei, R.; Izadkhah, V.; Mahmoodi, J.; Karamian, R.; Ahmadi Khoei, M. The synthesis of imidazoles and evaluation of their antioxidant and antifungal activities. Monatsh. Chem. Chem. Mon. 2018, 149, 1447–1452. [CrossRef]

Sorrenti, V.; Salerno, L.; Di Giacomo, C.; Acquaviva, R.; Siracusa, M.A.; Vanella, A. Imidazole derivatives as antioxidants and selective inhibitors of nNOS. Nitric Oxide 2006, 14, 45–50. [CrossRef] [PubMed]

Abdel-Wahab, B.F.; Awad, G.E.A.; Badria, F.A. Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles. Eur. J. Med. Chem. 2011, 46, 1505–1511. [CrossRef]

Giustarini, D.; Dalle-Donne, I.; Tsikas, D.; Rossi, R. Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers. Crit. Rev. Clin. Lab. Sci. 2009, 46, 241–281. [CrossRef]

Halliwell, B. Oxidative stress and neurodegeneration: Where are we now? J. Neurochem. 2006, 97, 1634–1658. [CrossRef]

Angoa Pérez, M.; Rivas Arancibia, S. Estrés oxidativo y neurodegeneración: ¿causa o consecuencia? Arch. Neurocien. 2007, 12, 45–54.

Tran, T.D.; Nguyen, T.C.V.; Nguyen, N.S.; Nguyen, D.M.; Nguyen, T.T.H.; Le, M.T.; Thai, K.M. Synthesis of novel chalcones as acetylcholinesterase inhibitors. Appl. Sci. 2016, 6, 198. [CrossRef]

Ferreira-Vieira, T.H.; Guimaraes, I.M.; Silva, F.R.; Ribeiro, F.M. Alzheimer’s Disease: Targeting the cholinergic system. Curr. Neuropharmacol. 2016, 14, 101–115. [CrossRef]

Da Costa, J.S.; Bizarro Lopes, J.P.; Russowsky, D.; Petzhold, C.L.; de Amorim Borges, A.C.; Ceschi, M.A.; Konrath, E.; Batassini, C.; Santana Lunardi, P.; Saraiva Gonçalves, C.A. Synthesis of tacrine-lophine hybrids via one-pot four component reaction and biological evaluation as acetyl- and butyrylcholinesterase inhibitors. Eur. J. Med. Chem. 2013, 62, 556–563. [CrossRef] [PubMed]

Molyneux P. The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity. Songklanakarin J Sci Technol 2004;26:211-9.

Ma L, Xiao Y, Li C, Xie ZL, Li DD, Wang YT, Ma HT, Zhu HL, Wang MH, Ye YH (2013) Synthesis and antioxidant activity of novel mannich base of 1,3,4- oxadiazole derivatives possessing 1,4-benzodioxan. Bioorg Med Chem 21(21):6763–6770 https://doi.org/https://doi.org/10.1016/j.bmc.2013.08.002.

Kumar A, Varadaraj BG, Singla RK (2013) Synthesis and evaluation of antioxidant activity of novel 3,5-disubstituted-2-pyrazolines. Bull Fac Pharm Cairo Univ 51(2:167–173 https://doi.org/https://doi.org/10.1016/j.bfopcu. 2013.04.002